These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16908424)
1. Etodolac-liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation. Barakat NS Drug Dev Ind Pharm; 2006 Aug; 32(7):865-76. PubMed ID: 16908424 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier. Hussein A; El-Menshawe S; Afouna M Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301 [TBL] [Abstract][Full Text] [Related]
3. Enhanced release of solid dispersions of etodolac in polyethylene glycol. Ozkan Y; Doganay N; Dikmen N; Işimer A Farmaco; 2000; 55(6-7):433-8. PubMed ID: 11204743 [TBL] [Abstract][Full Text] [Related]
4. The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures. Dey M; Enever R; Kraml M; Prue DG; Smith D; Weierstall R Pharm Res; 1993 Sep; 10(9):1295-300. PubMed ID: 8234166 [TBL] [Abstract][Full Text] [Related]
5. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. Eedara BB; Veerareddy PR; Jukanti R; Bandari S Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504 [TBL] [Abstract][Full Text] [Related]
6. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules. Karataş A; Bekmezci S Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368 [TBL] [Abstract][Full Text] [Related]
7. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology. Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191 [TBL] [Abstract][Full Text] [Related]
8. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies. Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Joshi HN; Tejwani RW; Davidovich M; Sahasrabudhe VP; Jemal M; Bathala MS; Varia SA; Serajuddin AT Int J Pharm; 2004 Jan; 269(1):251-8. PubMed ID: 14698596 [TBL] [Abstract][Full Text] [Related]
10. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Prabhu S; Ortega M; Ma C Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087 [TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol. Soliman MS; Khan MA Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610 [TBL] [Abstract][Full Text] [Related]
12. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660 [TBL] [Abstract][Full Text] [Related]
13. Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation. Ibrahim MM; El-Nabarawi M; El-Setouhy DA; Fadlalla MA AAPS PharmSciTech; 2010 Dec; 11(4):1730-7. PubMed ID: 21136309 [TBL] [Abstract][Full Text] [Related]
14. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour. Goddeeris C; Van den Mooter G Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442 [TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization of solid dispersion of furosemide with TPGS. Shin SC; Kim J Int J Pharm; 2003 Jan; 251(1-2):79-84. PubMed ID: 12527177 [TBL] [Abstract][Full Text] [Related]
16. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Sethia S; Squillante E Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063 [TBL] [Abstract][Full Text] [Related]
17. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods. Chen YC; Ho HO; Chiou JD; Sheu MT Int J Pharm; 2014 Oct; 473(1-2):458-68. PubMed ID: 25089508 [TBL] [Abstract][Full Text] [Related]
18. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284 [TBL] [Abstract][Full Text] [Related]
19. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules. Desai D; Kothari S; Huang M Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844 [TBL] [Abstract][Full Text] [Related]
20. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage. Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]